AMAT
54
-3
HUM
34
3
K
62
2
ZION
61
-2
KMX
48
-7
CI
52
7
ILMN
49
-2
TRIP
40
-4
FFIV
68
2
UA
51
-5
VNO
54
-5
HON
67
4
INTC
15
-3
STT
67
-4
SYK
48
2
GM
71
6
QCOM
55
-2
ORLY
53
4
FIS
63
5
PRU
54
6
AMAT
54
-3
HUM
34
3
K
62
2
ZION
61
-2
KMX
48
-7
CI
52
7
ILMN
49
-2
TRIP
40
-4
FFIV
68
2
UA
51
-5
VNO
54
-5
HON
67
4
INTC
15
-3
STT
67
-4
SYK
48
2
GM
71
6
QCOM
55
-2
ORLY
53
4
FIS
63
5
PRU
54
6
Financhill
Back

Galapagos NV 10K Form

Sell
38

GLPGF
Galapagos NV

Last Price:
$27.50
Seasonality Move:
-8.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GLPGF News And Ratings

See the #1 stock for the next 7 days that we like better than GLPGF

GLPGF Financial Statistics

Sales & Book Value

Annual Sales: $298.3M
Cash Flow: $-46.1M
Price / Cash Flow: 0
Annual Sales: $45.13
Price / Book: 0.61

Profitability

EPS (TTM): -2.74270
Net Income (TTM): $-180.2M
Gross Margin: $260.6M
Return on Equity: -5.84%
Return on Assets: -3.98%

Galapagos NV Earnings Forecast

Key Galapagos NV Financial Ratios

  • The Gross Profit Margin over the past 21 years for GLPGF is 87.35%.
  • The Selling, General & Administrative Expenses for GLPGF have been equal to 35.15% of Gross Profit Margin.
  • The Research & Development expenses have been 121.70% of Revenue.
  • The Interest Expense is 1.23% of Operating Income.
  • The Net Earning history of GLPGF is 26.88% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 10 years.

Galapagos NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: GLPGF
Website: glpg.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 7.95
Quick Ratio: 7.74

Price-to-Earnings

Trailing P/E Ratio: 22.69
Forward P/E Ratio: 0

GLPGF Technical Analysis vs Fundamental Analysis

Sell
38
Galapagos NV (GLPGF) is a Sell

Is Galapagos NV a Buy or a Sell?

  • Galapagos NV stock is rated a Sell
    The current Galapagos NV [GLPGF] share price is $27.50. The Score for GLPGF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.